Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 260

1.

Reduction in short-acting insulin requirement accompanies improved glycemic control with basal insulin peglispro compared to insulin glargine in patients with type 1 diabetes.

Rosenstock J, Blevins TC, Bergenstal RM, Morrow LA, Qu Y, Jacober SJ.

J Diabetes. 2015 Aug 17. doi: 10.1111/1753-0407.12332. [Epub ahead of print] No abstract available.

PMID:
26278063
2.

Analytical model of reactive transport processes with spatially variable coefficients.

Simpson MJ, Morrow LC.

R Soc Open Sci. 2015 May 20;2(5):140348. doi: 10.1098/rsos.140348. eCollection 2015 May.

3.

Prosthetic rehabilitation of the gagging patient using acrylic training plates.

Ali R, Altaie A, Morrow L.

Dent Update. 2015 Jan-Feb;42(1):52-4, 56-8.

PMID:
26062279
4.

An exploratory analysis linking neuropsychological testing to quantification of tractography using High Definition Fiber Tracking (HDFT) in military TBI.

Presson N, Beers SR, Morrow L, Wagener LM, Bird WA, Van Eman G, Krishnaswamy D, Penderville J, Borrasso AJ, Benso S, Puccio A, Fissell C, Okonkwo DO, Schneider W.

Brain Imaging Behav. 2015 May 9. [Epub ahead of print]

PMID:
25953056
5.

Subcutaneous Injection Depth Does Not Affect the Pharmacokinetics or Glucodynamics of Insulin Lispro in Normal Weight or Healthy Obese Subjects.

de la Peña A, Yeo KP, Linnebjerg H, Catton E, Reddy S, Brown-Augsburger P, Morrow L, Ignaut DA.

J Diabetes Sci Technol. 2015 Jul;9(4):824-30. doi: 10.1177/1932296815573865. Epub 2015 Feb 19.

PMID:
25697717
6.

Understanding the relative binding ability of hydroxyfullerene to divalent and trivalent metals.

Heimann J, Morrow L, Anderson RE, Barron AR.

Dalton Trans. 2015 Mar 7;44(9):4380-8. doi: 10.1039/c4dt03376k.

PMID:
25645489
7.

Pharmacodynamic effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, from a randomized study in patients with type 2 diabetes.

Sha S, Devineni D, Ghosh A, Polidori D, Hompesch M, Arnolds S, Morrow L, Spitzer H, Demarest K, Rothenberg P.

PLoS One. 2014 Sep 30;9(9):e110069. doi: 10.1371/journal.pone.0110069. eCollection 2014.

8.

Albiglutide does not impair the counter-regulatory hormone response to hypoglycaemia: a randomized, double-blind, placebo-controlled, stepped glucose clamp study in subjects with type 2 diabetes mellitus.

Hompesch M, Jones-Leone A, Carr MC, Matthews J, Zhi H, Young M, Morrow L, Reinhardt RR.

Diabetes Obes Metab. 2015 Jan;17(1):82-90. doi: 10.1111/dom.12398. Epub 2014 Oct 26.

PMID:
25263215
9.

Pharmacodynamic effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, from a randomized study in patients with type 2 diabetes.

Sha S, Devineni D, Ghosh A, Polidori D, Hompesch M, Arnolds S, Morrow L, Spitzer H, Demarest K, Rothenberg P.

PLoS One. 2014 Aug 28;9(8):e105638. doi: 10.1371/journal.pone.0105638. eCollection 2014.

10.

Canagliflozin, a sodium glucose co-transporter 2 inhibitor, reduces post-meal glucose excursion in patients with type 2 diabetes by a non-renal mechanism: results of a randomized trial.

Stein P, Berg JK, Morrow L, Polidori D, Artis E, Rusch S, Vaccaro N, Devineni D.

Metabolism. 2014 Oct;63(10):1296-303. doi: 10.1016/j.metabol.2014.07.003. Epub 2014 Jul 9.

11.

Pain and decreased cognitive function negatively impact physical functioning in older adults with knee osteoarthritis.

Morone NE, Abebe KZ, Morrow LA, Weiner DK.

Pain Med. 2014 Sep;15(9):1481-7. doi: 10.1111/pme.12483. Epub 2014 Jul 8.

PMID:
25040845
12.
13.

A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.

King TE Jr, Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, Gorina E, Hopkins PM, Kardatzke D, Lancaster L, Lederer DJ, Nathan SD, Pereira CA, Sahn SA, Sussman R, Swigris JJ, Noble PW; ASCEND Study Group.

N Engl J Med. 2014 May 29;370(22):2083-92. doi: 10.1056/NEJMoa1402582. Epub 2014 May 18. Erratum in: N Engl J Med. 2014 Sep 18;371(12):1172.

14.

Safety, efficacy and weight effect of two 11β-HSD1 inhibitors in metformin-treated patients with type 2 diabetes.

Heise T, Morrow L, Hompesch M, Häring HU, Kapitza C, Abt M, Ramsauer M, Magnone MC, Fuerst-Recktenwald S.

Diabetes Obes Metab. 2014 Nov;16(11):1070-7. doi: 10.1111/dom.12317. Epub 2014 Jun 9.

PMID:
24828020
15.

Gut hormone pharmacology of a novel GPR119 agonist (GSK1292263), metformin, and sitagliptin in type 2 diabetes mellitus: results from two randomized studies.

Nunez DJ, Bush MA, Collins DA, McMullen SL, Gillmor D, Apseloff G, Atiee G, Corsino L, Morrow L, Feldman PL.

PLoS One. 2014 Apr 3;9(4):e92494. doi: 10.1371/journal.pone.0092494. eCollection 2014.

16.

T cell interleukin-15 surface expression in chimpanzees infected with human immunodeficiency virus.

Rodriguez AR, Hodara V, Murthy K, Morrow L, Sanchez M, Bienvenu AE, Murthy KK.

Cell Immunol. 2014 Mar-Apr;288(1-2):24-30. doi: 10.1016/j.cellimm.2014.01.009. Epub 2014 Feb 6.

17.

Pharmacokinetic and pharmacodynamic responses of insulin degludec in African American, white, and Hispanic/Latino patients with type 2 diabetes mellitus.

Hompesch M, Morrow L, Watkins E, Roepstorff C, Thomsen HF, Haahr H.

Clin Ther. 2014 Apr 1;36(4):507-15. doi: 10.1016/j.clinthera.2013.12.014. Epub 2014 Feb 5.

18.

The management of lower back pain.

Morrow LJ, Smith S.

J R Nav Med Serv. 2014;100(3):282-7.

PMID:
25895408
19.

Technique tips--greenstick modification of dentures Prior to the replica technique: 'how we do it'.

Beddis HP, Morrow LA.

Dent Update. 2013 Oct;40(8):688. No abstract available.

PMID:
24279222
20.

Development and validation of a risk calculator for predicting postoperative pneumonia.

Gupta H, Gupta PK, Schuller D, Fang X, Miller WJ, Modrykamien A, Wichman TO, Morrow LE.

Mayo Clin Proc. 2013 Nov;88(11):1241-9. doi: 10.1016/j.mayocp.2013.06.027.

PMID:
24182703
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk